Incyte (INCY) Change in Receivables (2010 - 2026)
Incyte posted quarterly Change in Receivables of $27.0 million for Q1 2026, up 187.31% year-on-year from $9.4 million in Q1 2025, and down 78.97% on a QoQ basis from $128.5 million in Q4 2025.
Incyte (INCY) has 17 years of Change in Receivables data on file, last reported at $27.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 187.31% year-over-year to $27.0 million; the trailing twelve-month figure through Mar 2026 stood at $228.8 million (up 190.81% YoY), and the FY2025 full-year result was $170.8 million, up 53.04% from the prior year.
- Change in Receivables for Q1 2026 stood at $27.0 million, down from $128.5 million in the prior quarter.
- Across five years, Change in Receivables topped out at $128.5 million in Q4 2025 and bottomed at -$64.8 million in Q3 2022.
- The 5-year median for Change in Receivables is $19.4 million (2024), against an average of $25.7 million.
- Peak annual rise in Change in Receivables reached 412.37% in 2025, while the deepest fall reached 1672.12% in 2025.
- A 5-year view of Change in Receivables shows it stood at $26.7 million in 2022, then surged by 223.31% to $86.3 million in 2023, then advanced by 12.05% to $96.7 million in 2024, then surged by 32.89% to $128.5 million in 2025, then tumbled by 78.97% to $27.0 million in 2026.
- The last three Change in Receivables figures came in at $27.0 million (Q1 2026), $128.5 million (Q4 2025), and $53.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 27.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.03 Mn |
| Mar 31, 2026 | 27.03 Mn |
| Dec 31, 2025 | 128.50 Mn |
| Dec 31, 2025 | 128.50 Mn |
| Sep 30, 2025 | 53.00 Mn |
| Sep 30, 2025 | 53.00 Mn |
| Jun 30, 2025 | 20.23 Mn |
| Jun 30, 2025 | 20.23 Mn |
| Mar 31, 2025 | -30.96 Mn |
| Mar 31, 2025 | -30.96 Mn |
| Dec 31, 2024 | 96.69 Mn |
| Dec 31, 2024 | 96.69 Mn |
| Sep 30, 2024 | 19.40 Mn |
| Sep 30, 2024 | 19.40 Mn |
| Jun 30, 2024 | -6.48 Mn |
| Jun 30, 2024 | -6.48 Mn |
| Mar 31, 2024 | 1.97 Mn |
| Mar 31, 2024 | 1.97 Mn |
| Dec 31, 2023 | 86.29 Mn |
| Dec 31, 2023 | 86.29 Mn |
| Sep 30, 2023 | 19.27 Mn |
| Sep 30, 2023 | 19.27 Mn |
| Jun 30, 2023 | 14.21 Mn |
| Jun 30, 2023 | 14.21 Mn |
| Mar 31, 2023 | -21.09 Mn |
| Mar 31, 2023 | -21.09 Mn |
| Dec 31, 2022 | 26.69 Mn |
| Dec 31, 2022 | 26.69 Mn |
| Sep 30, 2022 | -64.78 Mn |
| Sep 30, 2022 | -64.78 Mn |
| Jun 30, 2022 | 120.62 Mn |
| Jun 30, 2022 | 120.62 Mn |
| Mar 31, 2022 | -53.96 Mn |
| Mar 31, 2022 | -53.96 Mn |
| Dec 31, 2021 | 99.61 Mn |
| Dec 31, 2021 | 99.61 Mn |
| Sep 30, 2021 | 78.52 Mn |
| Sep 30, 2021 | 78.52 Mn |
| Jun 30, 2021 | 40.81 Mn |
| Jun 30, 2021 | 40.81 Mn |
| Mar 31, 2021 | -84.64 Mn |
| Mar 31, 2021 | -84.64 Mn |
| Dec 31, 2020 | 117.53 Mn |
| Dec 31, 2020 | 117.53 Mn |
| Sep 30, 2020 | -64.07 Mn |
| Sep 30, 2020 | -64.07 Mn |
| Jun 30, 2020 | 77.01 Mn |
| Jun 30, 2020 | 77.01 Mn |
| Mar 31, 2020 | 42.71 Mn |
| Mar 31, 2020 | 42.71 Mn |
| Dec 31, 2019 | 32.69 Mn |
| Dec 31, 2019 | 32.69 Mn |
| Sep 30, 2019 | -26.56 Mn |
| Sep 30, 2019 | -26.56 Mn |
| Jun 30, 2019 | 58.60 Mn |
| Jun 30, 2019 | 58.60 Mn |
| Mar 31, 2019 | -63.52 Mn |
| Mar 31, 2019 | -63.52 Mn |
| Dec 31, 2018 | 59.86 Mn |
| Dec 31, 2018 | 59.86 Mn |
| Sep 30, 2018 | -68.57 Mn |
| Sep 30, 2018 | -68.57 Mn |
| Jun 30, 2018 | 96.12 Mn |
| Jun 30, 2018 | 96.12 Mn |
| Mar 31, 2018 | -46.11 Mn |
| Mar 31, 2018 | -46.11 Mn |
| Dec 31, 2017 | 67.95 Mn |
| Dec 31, 2017 | 67.95 Mn |
| Sep 30, 2017 | 28.83 Mn |
| Sep 30, 2017 | 28.83 Mn |
| Jun 30, 2017 | -75.46 Mn |
| Jun 30, 2017 | -75.46 Mn |
| Mar 31, 2017 | 96.22 Mn |
| Mar 31, 2017 | 96.22 Mn |
| Dec 31, 2016 | 17.24 Mn |
| Dec 31, 2016 | 17.24 Mn |
| Sep 30, 2016 | 3.89 Mn |
| Sep 30, 2016 | 3.89 Mn |
| Jun 30, 2016 | 15.99 Mn |
| Jun 30, 2016 | 15.99 Mn |
| Mar 31, 2016 | -13.17 Mn |
| Mar 31, 2016 | -13.17 Mn |
| Dec 31, 2015 | 27.48 Mn |
| Dec 31, 2015 | 27.48 Mn |
| Sep 30, 2015 | 11.84 Mn |
| Sep 30, 2015 | 11.84 Mn |
| Jun 30, 2015 | 5.52 Mn |
| Jun 30, 2015 | 5.52 Mn |
| Mar 31, 2015 | 11.67 Mn |
| Mar 31, 2015 | 11.67 Mn |
| Dec 31, 2014 | -51.67 Mn |
| Dec 31, 2014 | -51.67 Mn |
| Sep 30, 2014 | 62.39 Mn |
| Sep 30, 2014 | 62.39 Mn |
| Jun 30, 2014 | 811,000.00 |
| Jun 30, 2014 | 811,000.00 |
| Mar 31, 2014 | 11.02 Mn |
| Mar 31, 2014 | 11.02 Mn |
| Dec 31, 2013 | 2.18 Mn |
| Dec 31, 2013 | 2.18 Mn |
| Sep 30, 2013 | 5.68 Mn |
| Sep 30, 2013 | 5.68 Mn |
| Jun 30, 2013 | -519,000.00 |
| Jun 30, 2013 | -519,000.00 |
| Mar 31, 2013 | -42.91 Mn |
| Mar 31, 2013 | -42.91 Mn |
| Dec 31, 2012 | 54.41 Mn |
| Dec 31, 2012 | 54.41 Mn |
| Sep 30, 2012 | 2.70 Mn |
| Sep 30, 2012 | 2.70 Mn |
| Jun 30, 2012 | 831,000.00 |
| Jun 30, 2012 | 831,000.00 |
| Mar 31, 2012 | 6.60 Mn |
| Mar 31, 2012 | 6.60 Mn |
| Dec 31, 2011 | 3.95 Mn |
| Dec 31, 2011 | 3.95 Mn |
| Sep 30, 2011 | 86,000.00 |
| Sep 30, 2011 | 86,000.00 |
| Jun 30, 2011 | -14.20 Mn |
| Jun 30, 2011 | -14.20 Mn |
| Mar 31, 2011 | 10.88 Mn |
| Mar 31, 2011 | 10.88 Mn |
| Dec 31, 2010 | 966,000.00 |
| Dec 31, 2010 | 966,000.00 |
| Sep 30, 2010 | -1.63 Mn |
| Sep 30, 2010 | -1.63 Mn |
| Jun 30, 2010 | 1.11 Mn |
| Jun 30, 2010 | 1.11 Mn |
| Mar 31, 2010 | -158.41 Mn |
| Mar 31, 2010 | -158.41 Mn |